INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2019

Nicotinamide reduces transepidermal water loss and new non-melanoma skin cancers in high-risk humans.

This review examines the dermatologic roles of nicotinamide, a water-soluble vitamin B3 derivative, specifically for preventing photoaging and skin cancers. Nicotinamide prevents UV-induced ATP depletion and glycolysis inhibition, thereby enhancing DNA repair and lowering UV-induced immune suppression. Randomized controlled clinical trials noted in the review demonstrate that nicotinamide decreases transepidermal water loss and the occurrence of new non-melanoma skin cancers in high-risk humans.

Study type
Narrative review
Who was studied
Humans, including those at high risk of skin cancers
What was measured
Photoaging, skin cancer development, transepidermal water loss, safety

THE PAPER

Nicotinamide for photoprotection and skin cancer chemoprevention: A review of efficacy and safety.

Snaidr VA, Damian DL, Halliday GM. Exp Dermatol, 2019.

PubMed 30698874 ↗DOI 10.1111/exd.13819 ↗

CancerNutrients & adequacyHealthy aging & longevity

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.